| Sources | Names Used |
|---|---|
| CTRPv2 | triazolothiadiazine |
| PharmacoGx | triazolothiadiazine |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MDC1 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | TCOF1 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-08 |
| mRNA | CCAR2 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | LARS | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-08 |
| mRNA | NUP155 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-08 |
| mRNA | ANP32A | CTRPv2 | pan-cancer | AAC | 0.18 | 9e-08 |
| mRNA | FUBP1 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-08 |
| mRNA | LDLRAD2 | CTRPv2 | pan-cancer | AAC | -0.17 | 9e-08 |
| mRNA | ZNF280C | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | GSN | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
